2023
DOI: 10.3390/antiox12030595
|View full text |Cite
|
Sign up to set email alerts
|

Swietenine Alleviates Nonalcoholic Fatty Liver Disease in Diabetic Mice via Lipogenesis Inhibition and Antioxidant Mechanisms

Abstract: Our previous studies have reported the effect of swietenine (a major bioactive component of Swietenia macrophylla seeds) in reversing and potentiating the effect of metformin in hyperglycemia and hyperlipidaemia in diabetic rats. Moreover, we reported that the anti-inflammatory effect of swietenine is mediated via the activation of nuclear factor erythroid 2-related factor 2 (Nrf2). This study evaluated the effect of swietenine and its mechanisms in nonalcoholic fatty liver disease (NAFLD) in high-fat diet/str… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2023
2023
2025
2025

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(4 citation statements)
references
References 76 publications
0
4
0
Order By: Relevance
“…In addition, SREBP‐1c acts as a crucial transcription factor involved in adipose differentiation and adipogenesis in the liver, playing a vital role in the pathogenesis of NAFLD. [ 38 ] As a downstream marker molecule, FAS provides a nonesterified fatty acid substrate for TG, enhancing fatty acid synthesis and TG accumulation. [ 39 ] AMPKα1 directly regulates the phosphorylation of adipogenic SREBP‐1c and inhibits its activity, regulating the expression of FAS and reducing adipogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, SREBP‐1c acts as a crucial transcription factor involved in adipose differentiation and adipogenesis in the liver, playing a vital role in the pathogenesis of NAFLD. [ 38 ] As a downstream marker molecule, FAS provides a nonesterified fatty acid substrate for TG, enhancing fatty acid synthesis and TG accumulation. [ 39 ] AMPKα1 directly regulates the phosphorylation of adipogenic SREBP‐1c and inhibits its activity, regulating the expression of FAS and reducing adipogenesis.…”
Section: Discussionmentioning
confidence: 99%
“…Whereas in the immunohistochemistry study, the levels of Nrf2, NQO-1, and HO-1 were 2.53 ± 0.03, 1.59 ± 0.01, and 1.82 ± 0.02, respectively. 17 After 21 days of treatment with S. macrophylla seed extract, the average glucose and MDA levels in each of the following treatment groups: (DM + glibenclamide, DM + mahogany seed extract 10 mg/kg BW, DM + mahogany seed extract 20 mg/kg BW, and DM + mahogany seed extract 40 mg/kg BW) were significantly decrease over time. On day 0, the average serum MDA level in all groups increases by greater than 2 nmol/mL, except in the normal control group.…”
Section: In Vitro and In Vivo Studies On The Antioxidant Activity Of ...mentioning
confidence: 94%
“…Swi, a natural product, has been proved to be one of the few medicinal plants with anti diabetes effect [44] . Swi's recent research includes the treatment of various diseases caused by in ammation and oxidative stress [45] . According to reports, Swi can be accessed through NF-κB/NLRP3/Caspase-1 signaling pathway reduces in ammation and oxidative stress and improves DN [46] .…”
Section: Disscusionmentioning
confidence: 99%